Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector
The "Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector" program addresses the critical challenge of PFAS in healthcare. This initiative aims to develop innovative solutions for PFAS replacement, reduction, reuse, and end-of-life management, fostering cross-sectoral collaboration to enhance the European health industry's competitiveness and contribute to the EU Green Deal's sustainability goals.
Who is Funded: Eligible Participants and Program Objectives
This section outlines the eligibility criteria for organizations seeking funding under the PFAS management and alternatives program, detailing the types of entities, geographical scope, and overarching objectives for a healthier, more sustainable European healthcare sector.
What is Funded: Project Scope and Thematic Areas
This section details the types of projects and activities eligible for funding, focusing on innovative solutions for PFAS management in healthcare, from material development to waste treatment. It also clarifies the thematic areas and developmental stages targeted by the program.
Type and Scope of Funding: Financial Parameters
This section provides information on the financial aspects of the program, including the type of funding instrument, the maximum amount available per project, and general financial conditions.
Conditions and Requirements: Program Compliance
This section outlines the essential conditions and requirements for applicants and beneficiaries, covering administrative stipulations, collaboration rules, and specific financial provisions relevant to the program.
Application Procedure: Submission and Evaluation
This section provides an overview of the application process for the PFAS management and alternatives program, detailing the submission steps and the evaluation procedures.
Legal Basis: Foundational Documents and Regulations
This section outlines the foundational legal and official documents that establish and govern the "Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector" program, rooted within the broader Horizon Europe framework.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
24,000,000 €
Allocated Budget:
24,000,000 €
Deadline:
Closed as of 23.04.2025
Award Channel:
Framework Programme Call
Region:
European Union and Associated Countries, with potential participation from other non-EU/non-Associated Countries under specific provisions.
Sectors:
Healthcare, Medical Technology, Pharmaceutical Industry, Environmental and Climate Protection, Water and Waste Management, Research and Development, Other
Beneficiaries:
medical technology and medicines manufacturers and their supply chains, stakeholders involved in regulatory approval process (notified bodies, policy makers), waste management companies, hospitals, other healthcare settings and providers
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Basic Research
Funding Provider
Program Level:
European Union
Funding Body:
European Union (via Horizon Europe Framework Programme), Innovative Health Initiative Joint Undertaking (IHI JU)
Managed By:
Innovative Health Initiative Joint Undertaking (IHI JU)
Additional Partners:
EFPIA PFAS task force, Biophorum PFAS response team, Innovative Quality (Pharma) Consortium, American Chemical Society (ACS) Green Chemistry Institute Pharmaceutical Roundtable, Pharmaceutical Supply Chain Initiative (PSCI), Animal Health Europe (AhE), IMI/IMI2 JU and IHI JU consortia (PREMIER, iPiE, IHI Call 4 topic 5 project), Horizon 2020 projects, Horizon Europe calls, The Partnership for the Assessment of Risk from Chemicals (PARC), European Medicines Agency (EMA), European Directorate for the Quality of Medicines & HealthCare (EDQM), Official Medicines Control Laboratory (OMCL) network, national competent authorities, European Chemicals Agency (ECHA)
Website: